Brief: Gerresheimer Says It Expects A Stronger Q4 2025 Compared To Q3 2025, Mainly Due To Planned Production Ramp-Ups For Drug Delivery Systems
08/10/2025 23:01
Oct 8 (Reuters) - Gerresheimer AG GXIG.DE: EQS-NEWS: GERRESHEIMER: BUSINESS PERFORMANCE AND SLOWER MARKET GROWTH REQUIRE GUIDANCE ADJUSTMENT GERRESHEIMER AG: EXPECTS A STRONGER Q4 2025 COMPARED TO Q3 2025, MAINLY DUE TO PLANNED PRODUCTION RAMP-UPS FOR DRUG DELIVERY SYSTEMS Source text: ID:nEQbL37mka Further company coverage: GXIG.DE ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gerresheimer AG
See all newsGermany's Gerresheimer prelim Q3 revenue rises on strong demand for drug delivery devices
Brief: Gerresheimer Reports Q3 Revenue Of EUR 605 Mln
Brief: Gerresheimer Completes Sale Of Centor
Brief: Gerresheimer Targets Leverage At Or Below 3x Net Debt To Ebitda
Gerresheimer gains as Q2 shows quarter-on-quarter recovery